908 Devices Inc.

MASS • Medical - Specialties

$11.45

▼ -0.06 (-0.52%)

Current price

EarningsLatest report: Mar 31, 2026

HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.

Market Cap

$420.84M

Growth

-7.7%

Cash Flow

0/5

Trend

Negative

Evidence

Manageable debt level · 0.12Healthy liquidity · 4.24Negative growth trendWeak profitability

Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 6, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$11.45

Change-0.52%

Shares Out36.82M

Market Cap$420.84M

Enterprise Value$309.10M

52W Range5.03 - 9.34

Beta0.53

P/E-11.72

P/S7.28

P/B3.14

P/FCF-49.97

EV/Sales5.35

Price$11.45

Change-0.52%

Shares Out36.82M

Market Cap$420.84M

Enterprise Value$309.10M

52W Range5.03 - 9.34

Beta0.53

P/E-11.72

P/S7.28

P/B3.14

P/FCF-49.97

EV/Sales5.35

EV/EBITDA-11.63

EV/FCF-36.71

Earnings Yield-8.53%

FCF Yield-2.00%

Dividend Yield0.00%

Gross Margin47.68%

Oper. Margin-43.03%

Profit Margin-65.20%

Debt/Eq0.12

Current Ratio4.24

Quick Ratio3.86

Revenue 5Y-7.69%

Target$12.00

Target Upside4.80%

Target Median$12.00

Target Range12.00 - 12.00

Volume255.36K

Avg Volume271.34K

EPS Surprise-0.07

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

22/100

Financial Strength

Debt, cash, stability

76/100

Growth Potential

Revenue and expansion

27/100

Price Attractiveness

Cheap or expensive today

84/100

Why this score▼

Manageable debt level · 0.12Healthy liquidity · 4.24Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

MASS

Analyst sentiment

Based on 6 analyst votes · 2026-10-20

100/100

Bullish

Hold

Bearish

Price Target

2026-10-20

Low

$12.00

Mean

$12.00

Median

$12.00

High

$12.00

Company Overview

IPO: 12/18/2020

Industry: Medical - Specialties

P/B i: 3.14

Debt / Equity i: 0.12

Operating Margin: -43.03%

Net Margin: -65.20%

ROE i: -

ROIC: -

Financial Health

Score15 / 20

Debt / Equity: 0.12

Current Ratio: 4.24

Quick Ratio: 3.86

Status: Good

Insider Transactions

Recent executive and insider activity

Spoto Mark

Transaction: 06/11/2026

BUY

Change

+6,209

Price

$8.22

Filing

06/12/2026

Type

BUY

Spoto Mark

Transaction: 06/11/2026

BUY

Change

+13,656

Price

Not reported

Filing

06/12/2026

Type

BUY

CRANDELL KEITH

Transaction: 06/11/2026

BUY

Change

+6,209

Price

$8.22

Filing

06/12/2026

Type

BUY

Insider	Type	Change	Price	Transaction	Filing
Spoto Mark	BUY	+6,209	$8.22	06/11/2026	06/12/2026
Spoto Mark	BUY	+13,656	Not reported	06/11/2026	06/12/2026
CRANDELL KEITH	BUY	+6,209	$8.22	06/11/2026	06/12/2026
CRANDELL KEITH	BUY	+13,656	Not reported	06/11/2026	06/12/2026
ELOI FENEL M	BUY	+6,209	$8.22	06/11/2026	06/12/2026
ELOI FENEL M	BUY	+13,656	Not reported	06/11/2026	06/12/2026
Hunt Anthony	BUY	+6,209	$8.22	06/11/2026	06/12/2026
Hunt Anthony	BUY	+13,656	Not reported	06/11/2026	06/12/2026
HRUSOVSKY E KEVIN	BUY	+6,209	$8.22	06/11/2026	06/12/2026
HRUSOVSKY E KEVIN	BUY	+13,656	Not reported	06/11/2026	06/12/2026
Leonhart Michele M.	BUY	+6,209	$8.22	06/11/2026	06/12/2026
Leonhart Michele M.	BUY	+13,656	Not reported	06/11/2026	06/12/2026
Vann Brandi C	BUY	+6,209	$8.22	06/11/2026	06/12/2026
Vann Brandi C	BUY	+13,656	Not reported	06/11/2026	06/12/2026
Spoto Mark	SELL	-14,083	Not reported	06/10/2026	06/12/2026
Spoto Mark	BUY	+14,083	Not reported	06/10/2026	06/12/2026
CRANDELL KEITH	SELL	-14,083	Not reported	06/10/2026	06/12/2026
CRANDELL KEITH	BUY	+14,083	Not reported	06/10/2026	06/12/2026
ELOI FENEL M	SELL	-14,083	Not reported	06/10/2026	06/12/2026
ELOI FENEL M	BUY	+14,083	Not reported	06/10/2026	06/12/2026

About the Company

908 Devices Inc.

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.

Source - link

Peers

ACRS CAPR CERS CVRX NNOX NPCE QTRX SENS SGHT SNWV

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

Critical Contrast: TTM Technologies (NASDAQ:TTMI) versus 908 Devices (NASDAQ:MASS)

TTM Technologies (NASDAQ: TTMI - Get Free Report) and 908 Devices (NASDAQ: MASS - Get Free Report) are both technology companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk and profitability. Analyst Ratings This is a breakdown of recent

Defense World

908 Devices (NASDAQ:MASS) Hits New 52-Week High – Here’s What Happened

908 Devices Inc. (NASDAQ: MASS - Get Free Report)'s share price hit a new 52-week high during trading on Tuesday. The company traded as high as $13.30 and last traded at $12.8250, with a volume of 39458 shares trading hands. The stock had previously closed at $12.80. Wall Street Analyst Weigh In Several brokerages have issued

Defense World

Masivo Silver Reports Broad Polymetallic Mineralization from Initial 2026 Drilling Program at Cerro Colorado Project, Sonora, Mexico

Vancouver, British Columbia--(Newsfile Corp. - September 29, 2026) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) ("Masivo" or the "Company") is pleased to report encouraging analytical results from Drill Hole CC-26-001, the first drill hole completed as part of the Company's current exploration program at its Cerro Colorado Project in Sonora, Mexico. CC-26-001 intersected a broad polymetallic mineralized system, including 32.50 metres from 226.30 to 258.80 metres averaging 0.271% Zn, 7.0 g/t Ag, 0.141% Pb, 0.025% Cu and 0.01 g/t Au.

Newsfile Corp

Financial Analysis: IPG Photonics (NASDAQ:IPGP) vs. 908 Devices (NASDAQ:MASS)

IPG Photonics (NASDAQ: IPGP - Get Free Report) and 908 Devices (NASDAQ: MASS - Get Free Report) are both technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Profitability This table compares IPG Photonics and 908

Defense World

908 Devices (NASDAQ:MASS) SVP Sells $53,726.54 in Stock

908 Devices Inc. (NASDAQ: MASS - Get Free Report) SVP John Kenneweg sold 5,257 shares of the business's stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $10.22, for a total transaction of $53,726.54. Following the sale, the senior vice president owned 57,784 shares of the

Defense World

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-05-06	-0.15	-0.22	-0.07
2026-03-03	-0.06	-0.05	0.01
2025-11-10	-0.115	-0.15	-0.035
2025-08-05	-0.16	-0.18	-0.02
2025-05-13	-0.27	-0.22	0.05
2025-03-04	-0.35	-0.32	0.03
2024-11-12	-0.29	-0.23	0.06
2024-08-06	-0.34	-0.32	0.02
2024-04-30	-0.37	-0.33	0.04
2024-03-05	-0.27	-0.23	0.04
2023-11-07	-0.3	-0.22	0.08
2023-08-08	-0.33	-0.29	0.04